Drug Evaluation Committee Improving the Efficiency of Computerized System Validation in the GCP Domain
Electronic Information Subcommittee
March 2020
The use of electronic data is indispensable in improving the efficiency of various operations in pharmaceutical R&D and post-marketing activities. On the other hand, when computerizing operations in accordance with GxP regulations, regulations require computerized system validation (CSV) to clarify the requirements for computerized systems and to ensure that computerized systems operate as intended from the perspective of reliability assurance. In particular, the need to appropriately address the risks inherent in electronic data, including risks related to authenticity, readability, and retention, has raised the bar for the use of IT in the pharmaceutical industry. In addition, many regulations and guidelines related to CSV have been issued both domestically and internationally, and trends are changing rapidly. This makes it difficult for individual companies to gather sufficient information.
Therefore, Task Force 4 of the Electronic Information Subcommittee in FY 2018-2019 examined appropriate and efficient ways to promote CSV in the GCP area, and summarized "computerized system validation considering cost-effectiveness including cloud computing" and "efficient supplier audits and efficient use of CSV documents created by suppliers. Efficient supplier audits and efficient use of supplier-generated CSV documents" were summarized. We hope that this report will help companies to improve the efficiency of their CSV activities. For ease of use, the CSV document table is also available in Excel.
Deliverables of the Drug Evaluation Committee Return to list of all deliverables